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Objective. Cervical cancer patients who had an abandoned radical hysterectomy were evaluated for preoperative clinical predictors,
complication rates, and outcomes. Study Design. IRB approval was obtained for this retrospective analysis and chart review was
performed. Results. From 268 women with early-stage (IA2 to IIA) cervical cancer, 19 (7%) had an abandoned hysterectomy for
ﬁnding grossly positive lymph nodes (84%) or pelvic spread of tumor (16%). No clinical characteristics clearly identiﬁed women
preoperatively at risk of having an abandoned hysterectomy. In the abandoned group, 26% suﬀered major morbidities, compared
to 34% in the completed group (OR 0.69, [CI 0.16–2.57], P = .789). Thirty-seven percent recurred in the abandoned group,
compared to 18% in the completed group (P = .168). Overall survival in the abandoned group was 73% versus 80% in the
completed group (P = .772). Conclusion. The practice of abandoning a planned radical hysterectomy for unexpected metastatic
disease may not worsen the outcome.
1.Introduction
Cervical cancer aﬀects a large number of women with an
estimated450,000newcasesperyearglobally;approximately
10,000 are diagnosed annually in the U.S. [1]. The vast
majority of women will be diagnosed at early clinical stage
when cure rates are high. Early-stage (IA2 to IIA) carcinoma
of the cervix can be treated by radical hysterectomy (RH) or
primary radiotherapy (RT) with similar outcomes (ﬁve-year
overall survival 87%–92%) [2]. The choice of therapeutic
modality is based on patient comorbidities, and patient or
physician preference. Beneﬁts to surgical treatment include
simultaneous lymphadenectomy forsurgicalstaging [3]wi t h
possible therapeutic beneﬁt [4], preservation of ovarian
function in premenopausal women, and improved coital
function, as compared to RT [5–7].
H o w e v e r ,as u b s e to fw o m e nt r e a t e dw i t hp r i m a r y
surgery will require adjuvant postoperative chemoradiation
due to ﬁndings which confer a high risk of recurrence.
These include cancer spread to lymph nodes, invasion into
the parametria, and positive surgical margins [8]. In order
to avoid the combined morbidity of both methods of
treatment, many surgeons will abandon the radical hysterec-
tomy intraoperatively (termed abandoned or aborted radical
hysterectomy) if there are ﬁndings of disseminated disease,
s u c ha sp o s i t i v el y m p hn o d e s .T h i so c c u r si na p p r o x i m a t e l y
8%–10% of radical hysterectomies for early-stage cancer
[9, 10], and primary treatment with chemoradiation follows.
This is an area of controversy in gynecologic oncology,
and there is no consensus regarding the most appropriate
management. Further, data on preoperative identiﬁcation of
women who may be at risk of an abandoned hysterectomy is
lacking.
The ﬁnding of extra-cervical spread at the time of
exploration for radical surgery presents a challenging deci-
sion: proceed with planned hysterectomy knowing that the
patientwillrequirefurtherpostoperativetherapyorabandon
the procedure for primary chemoradiation. Therefore, we2 Obstetrics and Gynecology International
embarked on a review of cervical cancer patients at our
institution that had an abandoned radical hysterectomy
for preoperative clinical characteristics, morbidities and
survival.
2.MaterialsandMethods
IRB approval was obtained to review charts of patients
who underwent surgical exploration for early-stage cervical
cancer (Stage IB1-IIA) for the intent of radical hysterectomy
over a 10-year period at the University of Washington
Medical Center. We identiﬁed patients whose planned hys-
terectomy was abandoned due to intraoperative ﬁndings
of metastatic spread and abstracted data from medical
records on demographics, laboratory values, preoperative
radiologic imaging, operative reports, pathology specimens,
complications, recurrence, and overall survival. In addition,
we identiﬁed a group of early-stage patients who underwent
a radical hysterectomy and were found to have the high risk
feature of positive lymph nodes postoperatively to compare
morbidities and outcomes of therapy (completed group).
Statistical analysis was performed by Fisher’s exact method
between two variables and Log rank test to compare survival
probabilities.
3. Results
Between 1993 and 2003, 268 women with early-stage (IA2
t oI I A )c e r v i c a lc a n c e rp r e s e n t e df o rp r i m a r ys u r g i c a l
management with radical hysterectomy at our institution.
On review of operative reports, nineteen patients (7%)
had intraoperative abandonment of their planned radical
hysterectomy. The median age was 42 years old (range 29–
85) and approximately half were smokers (n = 9, 47%) with
median pack year history of 18. Most were stage IB1 (63%)
and squamous histology (79%) (Table 1).
Looking at other preoperative characteristics, the most
common presenting symptom was vaginal bleeding (n =
12, 68%), whereas only three (16%) of patients were
diagnosed following referral for an abnormal Pap smear.
The median number of years since prior Pap smear was
four (range 1–60). Median preoperative hematocrit and
hemoglobin were 34.5 and 12.0, respectively (range 29–41,
9.6–14.1). Preoperative imaging by CT scan was obtained
in 12/19 (63%). Of these, 50% (n = 6) had ﬁnd-
ings suspicious for pelvic lymphadenopathy (Table 1). No
patients had preoperative PET imaging during this study
period.
Thereasonsforabandonmentwerepositive pelviclymph
nodes (84%), positive paraaortic lymph nodes (16%) and/or
peritoneal spread (16%) by intraoperative frozen section.
Of the 16 patients who had abandonment for positive
pelvic lymph nodes, 25% were found to have positive para-
aortic or common iliac lymph nodes on ﬁnal pathology. In
total, 7 of 19 (37%) had positive para-aortic or common
iliac lymph nodes. The mean number of lymph nodes
removed was 23 (17 pelvic and 6 para-aortic, range 0–82)
and the mean number of positive lymph nodes was 2.7
(range 0–9).
Most women received deﬁnitive postoperative chemora-
diation therapy (12/19, 63%) or radiation alone (4/19, 32%).
One patient with adenocarcinoma spread to scalene nodes
underwent palliative chemotherapy and died of disease
within12months.Fivepatientsweretreatedwithconcurrent
5-FU and cisplatin, one with gemcitbine and cisplatin, and
sixwithcisplatinalone.Themedianradiationdosewas45Gy
(range 30.6–50.4) external beam whole pelvic and 85Gy
(range71–93)topointAwitheitherLDRorHDR.Following
radiation therapy, only three patients (16%) underwent
an adjuvant hysterectomy, and one (33%) had residual
disease.
We compared clinical characteristics, morbidity, and
mortality to a group of early-stage patients (n = 44) during
the same time period that had a completed radical hys-
terectomy, but were found postoperatively to have positive
pelvic lymph nodes (completed group). All received external
beam radiation or chemoradiation following radical surgery,
without brachytherapy. They were similar in demographic
makeup such as age, stage, and histology (Table 1). However,
they were more than twice as likely to present with an
abnormal Pap smear (32%), and time from prior Pap smear
wasmedian2.5years.Otherpreoperativecharacteristicssuch
as weight and hemoglobin were not appreciably diﬀerent
between the two groups (Table 1).
Next, we evaluated major complications, both operative-
and radiation-related. There were ﬁve major complications
in the abandoned group (26%): two operative-related (intra-
o p e r a t i v es t r o k ea n db o w e lp e r f o r a t i o np o s t o p e r a t i v e l y )a n d
threeradiation-related(severelymphedema,severeradiation
proctitis, requiring colostomy, and rectovaginal ﬁstula). In
the completed group, there were ﬁfteen major complications
(34%), ﬁve operative and 10 radiation-related (Table 2). The
diﬀerence in morbidity was not signiﬁcant.
Intheabandoned group, thereweresevenpatients (37%)
who experienced recurrence. Three (43%) had positive para-
aortic or common iliac lymph nodes, in addition to positive
pelvic lymph nodes. Recurrence site was pelvic in four
patients and distant in three. Of those with recurrence, only
two (29%) were able to be salvaged with exenteration and
ﬁve (71%) have died. Overall survival rate is 73% after two
years follow-up. In the completed group, eight patients had
recurrence (18%). Recurrence site was pelvic in four and
distant in four. Of this group, none were are able to salvaged
and one died of other causes, for an overall survival of 80%.
By Kaplan-Maier estimates, the progression-free and overall
survival diﬀerence between the two groups is not signiﬁcant
at the twoyear interval (Figures 1 and 2).
4. Comment
In our series of 268 women with early-stage cervical cancer,
19 (7%) had an abandoned hysterectomy when unexpected
spread of disease was found outside the cervix at time of
surgical exploration. We found patients with abandoned
hysterectomy presented more often with vaginal bleeding
(68%), as opposed to an abnormal Pap (16%), which
suggests that may the disease be further along in the patho-
genesis. Additionally, published reports have documentedObstetrics and Gynecology International 3
Table 1: Patient characteristics.
Abandoned (n = 19) Completed (n = 44) P
Age (Years)# 42 [41–54, 29–85] 44 [37–54, 21–85] .4207
Weight (kg)# 83 [65–85, 42–85] 71 [60–86, 41–121] .8727
Smoker (Yes) 9 (47%) 27 (61%) .4515
Pack per year# 18 [10–30, 2–52] 20 [10–30, 2–75] .682
Stage .4999
IB 0 (0%) 3 (7%)
IB1 12 (63%) 29 (66%)
IB2 5 (26%) 10 (23%)
IIA 1 (5%) 2 (5%)
IIB 1 (5%) 0 (0%)
Histology .6747
Squamous 14 (74%) 31 (70%)
Adenocarcinoma 4 (21%) 12 (27%)
Adenosquamous 1 (5%) 1 (2%)
Presenting symptoms .4407
Abnormal pap 3 (16%) 14 (32%)
Vaginal bleeding 13 (68%) 23 (52%)
Other 3 (16%) 3 (16%)
Preoperative labs
Hemoglobin# 12 [11.8–12.7, 9.6–14] 12.7 [12.1–13.4, 7.8–14.2] .3385
Hemotocrit# 34.5 [32–37, 29–41] 38 [35.8–39.3, 22–44] .2456
Prior pap (Years) 4 [2–9, 1–60] 2.5 [1–6,1–25] .2691
Preoperative CT scan
No 7 (37%) NR
Yes 12 (63%) NR
Suspicious 6 (50%) NR
#Median [IQR = interquartile Interval, Range = Minimum-Maximum].
NR = not recorded.
Table 2: Surgical-and radiation-related complications.
Complication Abandoned (N = 19) Completed (N = 44) OR, 95% CI and P-value
Surgical
Stroke 1 —
Bowel perforation/obstruction 1 1
Hemorrhage (>1500cc) — 1
Ureteral injury — 1
Iliac vein laceration — 1
Neurogenic/denervated bladder — 1
Total surgical complications 2/19 = 10% 5/44 = 11% (0.92, [0.08–6.633] and 1)
Radiation-related
Lymphedema 1 3
Radiation enteritis/proctitis 1 2
Bowel obstruction — 1
Severe diarrhea requiring TPN — 1
Rectovaginal ﬁstula 1 —
Radiation cystitis — 2
Vaginal stenosis — 1
Total radiation complications 3/19 = 16% 10/44 = 23% (0.64, [0.10–2.98] and 0.738)
Total 5/19 = 26% 15/44 = 34% (0.69, [0.16–2.57] and 0.789)
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Figure 2: Overall survival at ﬁve years for abandoned hysterectomy
and completed hysterectomy groups.
length of time from prior Pap smear as an association with
more advanced disease and poorer outcome [11]. In our
group of patients who had an abandoned hysterectomy,
the average time from prior Pap smear was four years.
Therefore, increasing time from prior Pap smear may also be




[12–14]. We therefore hypothesized that women at risk of
an abandoned hysterectomy may be anemic on presentation
as a marker of more advanced disease. However, median
preoperative hemoglobin and hematocrit were not markedly
low in our group.
The use of preoperative imaging with CT or PET-CT
is increasingly becoming the standard of care in the US to
help identify metastatic disease [15, 16]. Although our study
cohort spanned a time prior to more widespread preopera-
tive imaging (only 63% of patients received), we identiﬁed
suspicious lymphadenopathy in 50% of the patients who
underwent a CT scan. Suspicious lymph nodes on CT alone
are typically reported by size criteria as greater than 10mm.
Therefore, lymph nodes that have normal size may still
harbor “microscopic” spread and will be missed on CT. PET-
CT may be able to overcome some of these limitations and
currently is approved for preoperative workup of metastatic
disease in the US. Overall PET-CT has been shown to have
a sensitivity and speciﬁcity of 75% and 96% for detecting
nodal metastasis [17]. However, some investigators have
found lower sensitivity in women with early-stage disease
[18], but we still recommend patients with newly diagnosed
invasive cervical cancer to undergo a PET-CT to aid in
treatment planning if feasible.
Despite best eﬀorts to identify preoperatively patients
who have metastatic disease, there will still be patients who
on surgical exploration have metastatic disease. Controversy
exists as to the best management; whether to proceed with
radical hysterectomy or abandon for deﬁnitive chemoradia-
tion. When there is disseminated disease to the peritoneum
or abdomen, the prognosis is poor enough that there is little
doubt that radical surgery will contribute signiﬁcantly to
improving outcome. Additionally, the ﬁnding of grossly pos-
itive para-aortic lymph nodes confers worse prognosis with
ﬁve year overall survival of rates of 30%–40%. Performing
radical surgery in this setting is unlikely to improve and
may delay deﬁnitive treatment for recovery time. However,
it is recommended to attempt surgical resection of grossly
enlarged lymph nodes to improve radiation response and
possibly improve survival [4, 19].
The ﬁnding of positive pelvic lymph nodes when explor-
ing for radical surgery presents a unique dilemma. There
are no prospective clinical trials randomizing patients into
abandoned versus completed radical hysterectomy when
unexpected metastatic disease to pelvic lymph nodes is
found. Proponents for abandoning argue that patients suﬀer
less radiation toxicity to small bowel, rectum, and bladder
when the uterus is left in place, and have shorter interval
to recovery and deﬁnitive treatment. Those in favor of
completing the hysterectomy argue that removal of the
primary tumor may reduce the recurrence risk with better
pelvic control and allow for improved survival.
The ﬁrst report that described the abandoned (or
aborted) radical hysterectomy in cervical cancer was from
1990, in which 15 women with aborted radical hysterec-
tomy were matched with 15 women who had completed
hysterectomy, but were found to have positive nodes onObstetrics and Gynecology International 5
Table 3: Summary of published reports of abandoned hysterectomy.
Author Stage N Morbidity+ Recurrence Survival
Potter et al. [9] IB-IIA 15 7% 53% 45%–50%
Hopkins and Morley [20] IB-IIA 14 16% NR 50%
Bremer et al. [21] IB-IIA 26 45% 39% 61%
Whitney and Stehman [22] IB 68 19% 65% 31%
Leath et al. [23] IB-IIA 23 34% 26% 83%
S u p r a s e r te ta l .[ 24] IB-IIA 23 48% 26% 59%
Richard et al. [10] IB 55 NR NR 71%
Gray 2010 IB-IIA 19 26% 37% 73%
Total Abandoned 243 7%–48% 26%–65% 31%–83%
+Morbidities are combination of surgical-and-radiation related.
pathologic examination after surgery. They excluded all
patients with positive para-aortic lymph nodes. Still, survival
rate was 45% in the abandoned group versus 30% in the
completed group, with only one case of radiationrelated
morbidity (7%), which is low compared to most reports
[9]. Hopkins and Morley reported in 1991 on 14 patients
that had an abandoned hysterectomy, mostly for positive
lymph nodes, (57%) and compared to a group of 26 patients
found to have involved lymph nodes postoperatively. The
overall survival was 50% in the abandoned group compared
to 70% in the completed. Morbidities were higher (20%)
for the completed compared to the aborted group(16%)
[20].
In total, there have been seven retrospective series of
patients with abandoned hysterectomies reported in the
literature. Table 3 summarizes major ﬁndings between the
studies [9, 10, 20–24]. In general, the reported overall
survival ranges from 31%–83% at ﬁve years. The earlier
studies have a lower survival rate possibly due to lack of
chemotherapy paired with radiation. The reported morbidi-
ties vary greatly (range 7 to 48%) and are fraught with
reporting error, as these all are retrospective and patients are
commonly lost to follow-up.
In our study, we compared patients that had an
abandoned hysterectomy to a group of women that had
undergone radical hysterectomy, but had positive lymph
nodes postoperatively for morbidities, recurrence rates and
survival. There are clear limitations to using this control
group,aswomenfoundtohaveonlymicroscopicallypositive
l y m p hn o d e sw o u l di n h e r e n t l yb ee x p e c t e dt oh a v eh i g h e r
survival rates than women with gross or suspicious lymph
nodes. In our abandoned group, major toxicities related to
treatment were common (26%), but lower in the completed
group (34%), although this was not statistically signiﬁcant.
The increase appeared to be mostly due to increased severe
radiation-related toxicity (16% versus 23%). Only two
prior studies have reported on morbidity in the completed
(surgery + radiation) group, which ranged from 22%–29%
[20, 24]. One limitation of all of these retrospective studies,
including ours, is that the reporting of morbidity is not
standardized and can be underreported.
Progression free survival in our abandoned group was
lower than what would be expected for early-stage disease
(63%), although several patients were able to be salvaged
by exenteration for an overall survival of 73%. Our ﬁndings
weresimilartopreviouslyreportedstudies(Table 3).Amajor
limitation of this study is that it was underpowered to detect
ad i ﬀerence in survival between the abandoned group and
completed group.
In conclusion, individuals with clinically early-stage
cervical cancer who present with bleeding or long interval
from prior pap smear should be considered at risk for more
advanced disease. Preoperative imaging with CT or PET-
CT may help to evaluate for metastatic spread. If faced with
unexpected metastatic spread to pelvic lymph nodes at time
of surgical exploration, many surgeons will choose to aban-
don the radical hysterectomy for primary chemoradiation
therapy. However, completion of the hysterectomy in this
setting may not worsen morbidity or eﬀect overall survival.
As it is unlikely there will ever be a prospective randomized
trial to fully answer this question, our study suggests that
either option is viable and should be discussed with the
patient during the preoperative counseling.
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